| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Zhenhe Zhou, Hongmei Zhu, Lin Che. Effect of aripiprazole on mismatch negativity (MMN) in schizophrenia. PloS one. vol 8. issue 1. 2013-07-01. PMID:23308105. |
up to now, no studies for the effects of aripiprazole on mmn in schizophrenia have been reported. |
2013-07-01 |
2023-08-12 |
Not clear |
| Eunjin Cheon, Bon-Hoon Koo, Sang Soo Seo, Jun-Yeob Le. Two cases of hypersexuality probably associated with aripiprazole. Psychiatry investigation. vol 10. issue 2. 2013-06-27. PMID:23798970. |
we report hypersexuality symptoms in two female patients with schizophrenia who were receiving treatment with aripiprazole. |
2013-06-27 |
2023-08-12 |
Not clear |
| Jérôme Lerond, Amélie Lothe, Philippe Ryvlin, Sandrine Bouvard, Thierry d'Amato, Carolina Ciumas, Jean Daléry, Emmanuel Poulet, Mohamed Saou. Effects of aripiprazole, risperidone, and olanzapine on 5-HT1A receptors in patients with schizophrenia. Journal of clinical psychopharmacology. vol 33. issue 1. 2013-06-12. PMID:23277246. |
effects of aripiprazole, risperidone, and olanzapine on 5-ht1a receptors in patients with schizophrenia. |
2013-06-12 |
2023-08-12 |
human |
| Norio Yasui-Furukori, Akira Fuji. Worsened hypertension control induced by aripiprazole. Neuropsychiatric disease and treatment. vol 9. 2013-06-03. PMID:23723701. |
aripiprazole is widely used in the treatment of schizophrenia and bipolar disorders. |
2013-06-03 |
2023-08-12 |
Not clear |
| Pichai Ittasakul, Shefali Srivastava, Thanita Hiranyatheb, Terence A Kette. Torticollis after low-dose aripiprazole administration in a Thai schizophrenia patient. Asian journal of psychiatry. vol 5. issue 4. 2013-05-17. PMID:23174451. |
torticollis after low-dose aripiprazole administration in a thai schizophrenia patient. |
2013-05-17 |
2023-08-12 |
Not clear |
| Goro Sato, Shinpei Yoshimura, Hidehisa Yamashita, Yasumasa Okamoto, Shigeto Yamawak. The neurocognitive effects of aripiprazole compared with risperidone in the treatment of schizophrenia. Hiroshima journal of medical sciences. vol 61. issue 4. 2013-04-16. PMID:23342824. |
the neurocognitive effects of aripiprazole compared with risperidone in the treatment of schizophrenia. |
2013-04-16 |
2023-08-12 |
human |
| Goro Sato, Shinpei Yoshimura, Hidehisa Yamashita, Yasumasa Okamoto, Shigeto Yamawak. The neurocognitive effects of aripiprazole compared with risperidone in the treatment of schizophrenia. Hiroshima journal of medical sciences. vol 61. issue 4. 2013-04-16. PMID:23342824. |
the present study evaluates the comparative efficacy, effects on neurocognitive function, and adverse effects of aripiprazole and risperidone in the treatment of hospitalized patients with schizophrenia. |
2013-04-16 |
2023-08-12 |
human |
| Goro Sato, Shinpei Yoshimura, Hidehisa Yamashita, Yasumasa Okamoto, Shigeto Yamawak. The neurocognitive effects of aripiprazole compared with risperidone in the treatment of schizophrenia. Hiroshima journal of medical sciences. vol 61. issue 4. 2013-04-16. PMID:23342824. |
this double-blind, cross-over study included 23 patients with schizophrenia who were randomly assigned to be treated first with either aripiprazole or risperidone. |
2013-04-16 |
2023-08-12 |
human |
| Goro Sato, Shinpei Yoshimura, Hidehisa Yamashita, Yasumasa Okamoto, Shigeto Yamawak. The neurocognitive effects of aripiprazole compared with risperidone in the treatment of schizophrenia. Hiroshima journal of medical sciences. vol 61. issue 4. 2013-04-16. PMID:23342824. |
thus, for certain applications, aripiprazole may be a beneficial new treatment option for schizophrenia. |
2013-04-16 |
2023-08-12 |
human |
| Anna Synowiec, Ewa Gomółka, Tomasz Zyss, Andrzej Zieba, Ewa Florek, Wojciech Piekoszewsk. [Application of HPLC-UV method for aripiprazole determination in serum]. Przeglad lekarski. vol 69. issue 10. 2013-04-10. PMID:23421079. |
aripiprazole is a new drug applied in schizophrenia treatment. |
2013-04-10 |
2023-08-12 |
Not clear |
| Ariel Berger, John Edelsberg, Kafi N Sanders, Jose Ma J Alvir, Marko A Mychaskiw, Gerry Oste. Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort study. BMC psychiatry. vol 12. 2013-04-02. PMID:22856540. |
medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort study. |
2013-04-02 |
2023-08-12 |
Not clear |
| Ariel Berger, John Edelsberg, Kafi N Sanders, Jose Ma J Alvir, Marko A Mychaskiw, Gerry Oste. Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort study. BMC psychiatry. vol 12. 2013-04-02. PMID:22856540. |
schizophrenia and bipolar disorder are chronic debilitating disorders that are often treated with second-generation antipsychotic agents, such as aripiprazole, quetiapine, and ziprasidone. |
2013-04-02 |
2023-08-12 |
Not clear |
| Goyo Nagai, Kazuo Mihara, Akifumi Nakamura, Takeshi Suzuki, Kenji Nemoto, Shoko Kagawa, Ikuya Ohta, Hajime Arakaki, Tsuyoshi Kond. Prolactin concentrations during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of dopamine D2 receptor and cytochrome P450 2D6 in Japanese patients with schizophrenia. Psychiatry and clinical neurosciences. vol 66. issue 6. 2013-04-02. PMID:23066770. |
prolactin concentrations during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of dopamine d2 receptor and cytochrome p450 2d6 in japanese patients with schizophrenia. |
2013-04-02 |
2023-08-12 |
Not clear |
| Priya Khanna, Katja Komossa, Christine Rummel-Kluge, Heike Hunger, Sandra Schwarz, Hany George El-Sayeh, Stefan Leuch. Aripiprazole versus other atypical antipsychotics for schizophrenia. The Cochrane database of systematic reviews. issue 2. 2013-03-28. PMID:23450570. |
aripiprazole versus other atypical antipsychotics for schizophrenia. |
2013-03-28 |
2023-08-12 |
Not clear |
| Yoshiteru Takekita, Masaki Kato, Masataka Wakeno, Shiho Sakai, Azusa Suwa, Keiichiro Nishida, Gaku Okugawa, Toshihiko Kinoshit. A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients. Progress in neuro-psychopharmacology & biological psychiatry. vol 40. 2013-03-26. PMID:23022672. |
a 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of japanese schizophrenia patients. |
2013-03-26 |
2023-08-12 |
Not clear |
| Yoshiteru Takekita, Masaki Kato, Masataka Wakeno, Shiho Sakai, Azusa Suwa, Keiichiro Nishida, Gaku Okugawa, Toshihiko Kinoshit. A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients. Progress in neuro-psychopharmacology & biological psychiatry. vol 40. 2013-03-26. PMID:23022672. |
to evaluate the efficacy and safety of aripiprazole and perospirone in japanese patients with schizophrenia. |
2013-03-26 |
2023-08-12 |
Not clear |
| Jung Suk Lee, Jong Doo Lee, Hae-Jeong Park, Maeng-Keun Oh, Ji Won Chun, Se-Joo Kim, Eosu Kim, Jae-Jin Ki. Is the GABA System Related to the Social Competence Improvement Effect of Aripiprazole? An (18)F-Fluoroflumazenil PET Study. Psychiatry investigation. vol 10. issue 1. 2013-03-14. PMID:23482902. |
patients with schizophrenia who are treated with aripiprazole experience some benefits including an improvement of social competence, but the underlying mechanism of this improvement has not been investigated yet. |
2013-03-14 |
2023-08-12 |
Not clear |
| J Peuskens, C Bervoets, F Kok, B Delatte, G Touquet, B Gillain, A de Patoul, V Halkin, J-Y Loze, K Vansteelandt, E Constan. A prospective, multicentre, open-label study to evaluate the effectiveness of aripiprazole in the treatment of a broad range of patients with schizophrenia. European psychiatry : the journal of the Association of European Psychiatrists. vol 27. issue 7. 2013-03-05. PMID:21920707. |
a prospective, multicentre, open-label study to evaluate the effectiveness of aripiprazole in the treatment of a broad range of patients with schizophrenia. |
2013-03-05 |
2023-08-12 |
Not clear |
| J Peuskens, C Bervoets, F Kok, B Delatte, G Touquet, B Gillain, A de Patoul, V Halkin, J-Y Loze, K Vansteelandt, E Constan. A prospective, multicentre, open-label study to evaluate the effectiveness of aripiprazole in the treatment of a broad range of patients with schizophrenia. European psychiatry : the journal of the Association of European Psychiatrists. vol 27. issue 7. 2013-03-05. PMID:21920707. |
the aim of this study is to evaluate the effectiveness of 12-week treatment with aripiprazole in a broad range of patients suffering from schizophrenia by using a variety of physicians, caregivers and patients scales. |
2013-03-05 |
2023-08-12 |
Not clear |
| Jinbei Zhang, Xiaoli Wu, Feici Diao, Zhaoyu Gan, Zhiyong Zhong, Qingling Wei, Nianhong Gua. Association analysis of ZNF804A (zinc finger protein 804A) rs1344706 with therapeutic response to atypical antipsychotics in first-episode Chinese patients with schizophrenia. Comprehensive psychiatry. vol 53. issue 7. 2013-02-25. PMID:22425527. |
seventy-one first-episode inpatients with schizophrenia receiving olanzapine, aripiprazole, or quetiapine monotherapy were enrolled. |
2013-02-25 |
2023-08-12 |
Not clear |